Phase III study supports use of canagliflozin for type 2 diabetes in children and adolescents
A Phase III, international, randomized clinical trial assessed the safety and efficacy of canagliflozin for the treatment of type 2 diabetes mellitus (T2DM) in children and adolescents.
Aug 4, 2025
0
17








